Virginia Pascual‐Ramos

Author

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ORCID

Also Known As

Pascual-Ramos Virginia, V Pascual-Ramos, V. Pascual-Ramos, Virgina Pascual Ramos, Virginia Pascual-Ramos, Virginia Pascual-ramos, Virginia Pascual‐Ramos

126

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Harbor–UCLA Medical Center Diakonhjemmet Hospital Dudley Group NHS Foundation Trust University of Manitoba

About

Virginia Pascual‐Ramos is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in medicine, hearing loss, and rheumatic diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	171
2	Arts	1	1	50
3	Education	1	1	16
4	Engineering	1	1	13
5	Health Sciences	1	1	13

Virginia Pascual‐Ramos

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
A phase IIb dose‐ranging study of the oral JAK inhibitor tofacitinib (CP‐690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone Joel M. Kremer, Stanley Cohen, Bethanie Wilkinson, Arthritis & Rheumatism	2011	343
Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries Cynthia S. Crowson, Sherine E. Gabriel, Anne Grete Semb, Lara D. Veeken	2017	137
Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability Virginia Pascual‐Ramos, Irazú Contreras-Yáñez, Antonio Villa, Arthritis Research & Therapy	2009	93
Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. Virginia Pascual‐Ramos, Andrés Duarte‐Rojo, Antonio Villa, PubMed	2004	92
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial Andra Bălănescu, Gustavo Citera, Virginia Pascual‐Ramos, Annals of the Rheumatic Diseases	2022	62
Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort Luis Alonso González, Octavio Martínez Betancur, Graciela S. Alarcón, Seminars in Arthritis and Rheumatism Clinical FindingAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupus	2015	60
Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup? Luís J. Catoggio, Enrique R. Soriano, Patricia M. Imamura, Lupus	2014	59
Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort Guillermo Pons‐Estel, Graciela S. Alarcón, Leticia Susana Hachuel, Lara D. Veeken	2012	59
Sensorineural Hearing Loss-A Common Finding in Early-Onset Type 2 Diabetes Me Llitus Israel Lerman‐Garber, Daniel Cuevas‐Ramos, Samantha Valdés, Endocrine Practice Diabetes ManagementDiabetes Me LlitusDiabetesAudiologyHearing Disorders	2012	50
Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients Ida Kristiane Roelsgaard, Eirik Ikdahl, Silvia Rollefstad, Lara D. Veeken	2019	47

Page 1